T-cell activation promotes tumorigenesis in inflammation-associated cancer

por Rauch, Dan, Gross, Shimon, Harding, John, Bokhari, Sirosh, Niewiesk, Stefan, Lairmore, Michael, Piwnica-Worms, David, Ratner, Lee
Publicado 2009

Human T-Cell Leukemia Virus Type 1 (HTLV-1) Tax Requires CADM1/TSLC1 for Inactivation of the NF-κB Inhibitor A20 and Constitutive NF-κB Signaling

por Pujari, Rajeshree, Hunte, Richard, Thomas, Remy, van der Weyden, Louise, Rauch, Dan, Ratner, Lee, Nyborg, Jennifer K., Ramos, Juan Carlos, Takai, Yoshimi, Shembade, Noula
Publicado 2015

Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma

por Ratner, Lee, Ramos, JC, Noy, Ariela, Barta, Stefan, Parikh, Samir, Phillips, Adrienne, Ambinder, Richard, Rauch, Dan, Harding, John, Baydoun, Hicham, Cheng, Xiaogang, Caruso, Breanna, Jacobson, Steven
Publicado 2015